Zeta Corporation was founded in 2003 in the State of California, USA. We specialize in providing high quality popular IVD antibodies for pathologic diagnosis, guiding treatment and predicting prognosis of human cancers. We also provide IVD antibodies for cancer targeted therapy and immunotherapy due to gene mutations, translocations or amplifications. All of our antibodies work on formalin-fixed and paraffin embedded (FFPE) tissue sections. As an ISO 13485:2016 certified biomedical company, all of our antibody clones are scientifically selected to fit the need of clinical immunohistochemical laboratories. Our primary antibodies are manufactured by FDA certified GMP facilities and purified by affinity chromatography with >99% purity.